Acura Pharmaceuticals Return on Tangible Equity 2012-2021 | ACUR
Current and historical return on tangible equity values for Acura Pharmaceuticals (ACUR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Acura Pharmaceuticals Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2021-12-31 | $0.00B | $0.00B | 0.00% |
| 2021-09-30 | $0.00B | $0.00B | 0.00% |
| 2021-06-30 | $0.00B | $-0.01B | 22.22% |
| 2021-03-31 | $0.00B | $-0.01B | 17.39% |
| 2020-12-31 | $0.00B | $-0.01B | 36.36% |
| 2020-09-30 | $0.00B | $-0.01B | 36.36% |
| 2020-06-30 | $0.00B | $-0.01B | 18.18% |
| 2020-03-31 | $0.00B | $-0.01B | 69.57% |
| 2019-12-31 | $0.00B | $-0.01B | 69.57% |
| 2019-09-30 | $0.00B | $-0.01B | 72.73% |
| 2019-06-30 | $-0.01B | $-0.01B | 95.24% |
| 2019-03-31 | $0.00B | $-0.01B | 63.16% |
| 2018-12-31 | $0.00B | $0.00B | 70.59% |
| 2018-09-30 | $-0.01B | $0.00B | 153.85% |
| 2018-06-30 | $-0.01B | $0.00B | 300.00% |
| 2018-03-31 | $-0.01B | $0.00B | 466.67% |
| 2017-12-31 | $-0.01B | $0.00B | 800.00% |
| 2017-09-30 | $0.00B | $0.00B | 400.00% |
| 2017-06-30 | $0.00B | $0.00B | 200.00% |
| 2017-03-31 | $0.00B | $0.00B | 600.00% |
| 2016-12-31 | $-0.01B | 0 | -2400.00% |
| 2016-09-30 | $-0.01B | $0.00B | -514.29% |
| 2016-06-30 | $-0.01B | $0.00B | -250.00% |
| 2016-03-31 | $-0.01B | $0.01B | -222.22% |
| 2015-12-31 | $-0.01B | $0.01B | -120.00% |
| 2015-09-30 | $-0.01B | $0.00B | -188.24% |
| 2015-06-30 | $-0.01B | $0.00B | -200.00% |
| 2015-03-31 | $-0.01B | $0.01B | -163.64% |
| 2014-12-31 | $-0.01B | $0.01B | -180.65% |
| 2014-09-30 | $-0.01B | $0.01B | -121.74% |
| 2014-06-30 | $-0.01B | $0.02B | -91.80% |
| 2014-03-31 | $-0.01B | $0.02B | -71.23% |
| 2013-12-31 | $-0.01B | $0.02B | -63.41% |
| 2013-09-30 | $-0.01B | $0.02B | -56.52% |
| 2013-06-30 | $-0.01B | $0.03B | -47.52% |
| 2013-03-31 | $-0.01B | $0.03B | -38.94% |
| 2012-12-31 | $-0.01B | $0.03B | -29.03% |
| 2012-09-30 | $-0.01B | $0.03B | -24.06% |
| 2012-06-30 | $-0.01B | $0.04B | -22.70% |
| 2012-03-31 | $0.01B | $0.04B | 29.53% |
| 2011-12-31 | $0.01B | $0.03B | 29.20% |
| 2011-09-30 | $0.01B | $0.03B | 29.03% |
| 2011-06-30 | $0.01B | $0.03B | 28.57% |
| 2011-03-31 | $-0.01B | $0.03B | -48.48% |
| 2010-12-31 | $-0.01B | $0.03B | -49.52% |
| 2010-09-30 | $-0.01B | $0.03B | -50.45% |
| 2010-06-30 | $-0.02B | $0.03B | -51.28% |
| 2010-03-31 | $-0.02B | $0.03B | -61.79% |
| 2009-12-31 | $-0.02B | $0.03B | -48.48% |
| 2009-09-30 | $-0.02B | $0.04B | -43.17% |
| 2009-06-30 | $-0.01B | $0.04B | -21.92% |
| 2009-03-31 | $0.01B | $0.04B | 16.33% |
| 2008-12-31 | $0.01B | $0.03B | 41.18% |
| 2008-09-30 | $0.03B | $0.03B | 91.53% |
| 2008-06-30 | $0.02B | $0.02B | 100.00% |
| 2008-03-31 | $0.01B | $0.01B | 130.00% |
| 2007-12-31 | $0.00B | 0 | -1200.00% |
| 2007-09-30 | $-0.03B | $-0.01B | 207.14% |
| 2007-06-30 | $-0.03B | $-0.02B | 160.00% |
| 2007-03-31 | $-0.03B | $-0.02B | 177.14% |
| 2006-12-31 | $-0.03B | $-0.02B | 162.50% |
| 2006-09-30 | $-0.02B | $-0.01B | 212.50% |
| 2006-06-30 | $-0.02B | $-0.01B | 237.04% |
| 2006-03-31 | $-0.01B | $-0.01B | 254.55% |
| 2005-12-31 | $-0.01B | $-0.01B | 266.67% |
| 2005-09-30 | $-0.01B | $0.00B | 215.38% |
| 2005-06-30 | $-0.06B | $0.00B | 2800.00% |
| 2005-03-31 | $-0.07B | $-0.02B | 496.55% |
| 2004-12-31 | $-0.07B | $-0.02B | 293.62% |
| 2004-09-30 | $-0.08B | $-0.04B | 226.21% |
| 2004-06-30 | $-0.04B | $-0.05B | 93.48% |
| 2004-03-31 | $-0.04B | $-0.04B | 90.80% |
| 2003-12-31 | $-0.05B | $-0.04B | 133.33% |
| 2003-09-30 | $-0.07B | $-0.03B | 272.90% |
| 2003-06-30 | $-0.07B | $-0.04B | 189.04% |
| 2003-03-31 | $-0.07B | $-0.05B | 141.30% |
| 2002-12-31 | $-0.06B | $-0.06B | 102.16% |
| 2002-09-30 | $-0.03B | $-0.07B | 36.62% |
| 2002-06-30 | $-0.02B | $-0.07B | 30.19% |
| 2002-03-31 | $-0.02B | $-0.06B | 28.57% |
| 2001-12-31 | $-0.01B | $-0.06B | 22.13% |
| 2001-09-30 | $-0.01B | $-0.06B | 19.73% |
| 2001-06-30 | $-0.01B | $-0.05B | 24.41% |
| 2001-03-31 | $-0.01B | $-0.05B | 14.00% |
| 2000-12-31 | $-0.01B | $-0.05B | 22.80% |
| 2000-09-30 | $-0.02B | $-0.05B | 32.97% |
| 2000-06-30 | $-0.02B | $-0.04B | 37.43% |
| 2000-03-31 | $-0.02B | $-0.04B | 51.85% |
| 1999-12-31 | $-0.02B | $-0.04B | 54.05% |
| 1999-09-30 | $-0.02B | $-0.03B | 47.41% |
| 1999-06-30 | $-0.02B | $-0.03B | 48.78% |
| 1999-03-31 | $-0.01B | $-0.03B | 51.38% |
| 1998-12-31 | $-0.01B | $-0.02B | 54.17% |
| 1998-09-30 | $-0.02B | $-0.02B | 68.97% |
| 1998-06-30 | $-0.01B | $-0.02B | 76.71% |
| 1998-03-31 | $-0.01B | $-0.02B | 90.32% |
| 1997-12-31 | $-0.02B | $-0.01B | 117.65% |
| 1997-09-30 | $-0.02B | $-0.01B | 157.89% |
| 1997-06-30 | $-0.02B | $-0.01B | 213.33% |
| 1997-03-31 | $-0.02B | $-0.01B | 266.67% |
| 1996-12-31 | $-0.02B | $0.00B | 352.94% |
| 1996-09-30 | $-0.01B | $0.00B | 433.33% |
| 1996-06-30 | $-0.01B | $0.00B | 880.00% |
| 1996-03-31 | $-0.01B | $0.00B | -1200.00% |
| 1995-12-31 | $0.00B | $0.00B | -150.00% |
| 1995-09-30 | $0.00B | $0.00B | -88.89% |
| 1995-06-30 | $0.00B | $0.00B | -57.14% |
| 1995-03-31 | $0.00B | $0.00B | -66.67% |
| 1994-12-31 | $-0.01B | $0.00B | -333.33% |
| 1994-09-30 | $-0.01B | $0.00B | -254.55% |
| 1994-06-30 | $-0.01B | $0.01B | -180.00% |
| 1994-03-31 | $-0.01B | $0.01B | -141.94% |
| 1993-12-31 | $-0.01B | $0.01B | -104.76% |
| 1993-09-30 | $-0.01B | $0.01B | -52.83% |
| 1993-06-30 | $0.00B | $0.02B | -20.69% |
| 1993-03-31 | $0.00B | $0.02B | 6.78% |
| 1992-12-31 | $0.00B | $0.01B | 14.04% |
| 1992-09-30 | $0.00B | $0.01B | 22.22% |
| 1992-06-30 | $0.00B | $0.01B | 16.33% |
| 1992-03-31 | $0.00B | $0.01B | 8.89% |
| 1991-12-31 | $0.00B | $0.01B | 0.00% |
| 1991-09-30 | $0.00B | $0.01B | 0.00% |
| 1991-06-30 | $0.00B | $0.01B | 0.00% |
| 1991-03-31 | $0.00B | $0.01B | 0.00% |
| 1990-12-31 | $0.00B | $0.01B | 0.00% |
| 1990-09-30 | $0.00B | $0.01B | -12.12% |
| 1990-06-30 | $0.00B | $0.01B | -12.12% |
| 1990-03-31 | $0.00B | $0.01B | -12.12% |
| 1989-12-31 | $0.00B | $0.01B | -12.50% |
| 1989-09-30 | $0.00B | $0.01B | 12.90% |
| 1989-06-30 | $0.00B | $0.01B | 14.29% |
| 1989-03-31 | $0.00B | $0.01B | 15.38% |
| 1988-12-31 | $0.00B | $0.01B | 16.00% |
| 1988-09-30 | $0.00B | $0.01B | 0.00% |
| 1988-06-30 | $0.00B | $0.01B | 0.00% |
| 1988-03-31 | $0.00B | $0.01B | 0.00% |
| 1987-12-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |